MedPath

江苏万高药业股份有限公司

Ownership
-
Established
2003-11-28
Employees
-
Market Cap
-
Website
http://www.wangao.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

80

NMPA:80

Drug Approvals

Desloratadine oral solution

Product Name
地氯雷他定口服溶液
Approval Number
国药准字H20254327
Approval Date
May 27, 2025
NMPA

Choline Fenofibrate Sustained-release Capsules

Product Name
非诺贝特酸胆碱缓释胶囊
Approval Number
国药准字H20254219
Approval Date
May 20, 2025
NMPA

Choline Fenofibrate Sustained-release Capsules

Product Name
非诺贝特酸胆碱缓释胶囊
Approval Number
国药准字H20254220
Approval Date
May 20, 2025
NMPA

Saxagliptin and Metformin Hydrochloride Sustained-release Tablets(Ⅲ)

Product Name
沙格列汀二甲双胍缓释片(Ⅲ)
Approval Number
国药准字H20254116
Approval Date
May 13, 2025
NMPA

Vardenafil Hydrochloride Tablets

Product Name
盐酸伐地那非片
Approval Number
国药准字H20254130
Approval Date
May 13, 2025
NMPA

Vardenafil Hydrochloride Tablets

Product Name
盐酸伐地那非片
Approval Number
国药准字H20254129
Approval Date
May 13, 2025
NMPA

Saxagliptin and Metformin Hydrochloride Sustained-release Tablets(Ⅰ)

Product Name
沙格列汀二甲双胍缓释片(Ⅰ)
Approval Number
国药准字H20254115
Approval Date
May 13, 2025
NMPA

Procaterol Hydrochloride Tablets

Product Name
盐酸丙卡特罗片
Approval Number
国药准字H20253841
Approval Date
Apr 8, 2025
NMPA

Levofloxacin Eye Drops

Product Name
左氧氟沙星滴眼液
Approval Number
国药准字H20253857
Approval Date
Apr 8, 2025
NMPA

Dapagliflozin Tablets

Product Name
达格列净片
Approval Number
国药准字H20253768
Approval Date
Apr 1, 2025
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.